Biological and Molecular Factors Predicting Response to Adoptive Cell Therapies in Cancer JNCI-J NATL CANCER I
Bone Marrow Stromal Cell Regeneration Profile in Treated B-Cell Precursor Acute Lymphoblastic Leukemia Patients: Association with MRD Status and Patient Outcome CANCERS
CD34+CD19-CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies BLOOD
Ocular involvement in patients with primary central-nervous-system lymphoma: Analysis of a multicentre study in Spain BRIT J HAEMATOL
Detection of oncogenic and clinically actionable mutations in cancer genomes critically depends on variant calling tools BIOINFORMATICS
A diphtheria toxin-based nanoparticle achieves specific cytotoxic effect on CXCR4(+) lymphoma cells without toxicity in immunocompromised and immunocompetent mice BIOMED PHARMACOTHER
Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory FLT3-ITD Mutation-Positive Acute Myeloid Leukemia CANCERS
Follow-up of patients with R/R FLT3-mutation-positive AML treated with gilteritinib in the phase 3 ADMIRAL trial BLOOD
Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT (vol 57, pg 416, 2022) BONE MARROW TRANSPL